High turnover renal osteodystrophy due to secondary hyperparathyroidism diagnosed by 18F-Fluorocholine combined with 18F-NaF PET/CT

High turnover renal osteodystrophy due to secondary hyperparathyroidism diagnosed by 18F-Fluorocholine combined with 18F-NaF PET/CT

Bibliographic Details
Main Authors:	Lin Xiong, Weihua Wu, Yue Chen, Liang Cai, Santao Ou
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	Renal Failure
Online Access:	http://dx.doi.org/10.1080/0886022X.2021.1918165

Similar Items

<sup>18</sup>F-Fluorocholine PET/CT, Tc-99m-MIBI and TC-99m-MDP SPECT/CT in Tertiary Hyperparathyroidism with Renal Osteodystrophy
by: Cristina Ferrari, et al.
Published: (2020-10-01)

Incremental role of 18F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism
by: Abhishek Behera, et al.
Published: (2016-01-01)

The Significance of 18F-Fluorocholine-PET/CT as Localizing Imaging Technique in Patients with Primary Hyperparathyroidism and Negative Conventional Imaging
by: Stefan Fischli, et al.
Published: (2018-01-01)

The role of 18F–NaF PET/CT in metastatic bone disease
by: Mine Araz, et al.
Published: (2015-09-01)

Complementary findings on 18F-FDG PET/CT and 18F-NaF PET/CT in a patient with Erdheim-Chester disease
by: Daniela Sabino, et al.

<sup>18</sup>F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism
by: Valentin Pretet, et al.
Published: (2020-06-01)

18F-PSMA-1007 and 18F-fluorocholine PET/CT in prostate cancer progression diagnostics. First comparative experience
by: N. A. Meshcheriakova, et al.
Published: (2019-10-01)

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [18F]fluorocholine PET/CT
by: Sandi A. Kwee, et al.
Published: (2015-05-01)

Optimal scan time for evaluation of parathyroid adenoma with [18F]-fluorocholine PET/CT
by: Rep Sebastijan, et al.
Published: (2015-12-01)

Prevalence of exclusive lower extremity metastases at 18F-NaF PET/CT
by: Monique Beraldo Ordones, et al.
Published: (2015-06-01)

Comparison of 18F-NaF PET/CT and 18F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma
by: Yin Zhang, et al.
Published: (2018-01-01)

Dual-stage 18F-fluorocholine PET/CT scanning for biochemical recurrences of prostate cancer
by: M. B. Dolgushin, et al.
Published: (2015-06-01)

A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis
by: Kalevi Kairemo, et al.
Published: (2021-12-01)

Review of the article “ 18F-PSMA-1007 and 18F-fluorocholine PET/CT in prostate cancer progression diagnostics. First comparative experience”
by: O V. Muxortova
Published: (2019-10-01)

Parathyroid imaging with 18F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study
by: Wouter A. M. Broos, et al.
Published: (2019-07-01)

Receiver operating characteristic (ROC) curve for classification of18F-NaF uptake on PET/CT
by: Agnes Araujo Valadares, et al.
Published: (2016-02-01)

Cutaneous and Vascular Deposits of 18F-NaF by PET/CT in the Follow-Up of Patients with Pseudoxanthoma Elasticum
by: Eugenia Lillo, et al.
Published: (2021-06-01)

Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer
by: Matteo Sepulcri, et al.
Published: (2021-09-01)

Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France
by: Mathieu Gauthé, et al.
Published: (2020-03-01)

Misleading localization by 18F-fluorocholine PET/CT in familial hypocalciuric hypercalcemia type-3: a case report
by: Noha N Mukhtar, et al.
Published: (2021-01-01)

Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [18F]DCFPyL-PET: comparison to [18F]fluorocholine-PET
by: Dae-Myoung Yang, et al.
Published: (2021-01-01)

The Pharmacokinetics of F-18 Fluorocholine in Detecting Breast Cancer Patients
by: Shazreen Shaharuddin, et al.
Published: (2020-11-01)

Shining dead bone—cause for cautious interpretation of [18F]NaF PET scans
by: Magnus Bernhardsson, et al.
Published: (2018-01-01)

Normal SUV values measured from NaF18- PET/CT bone scan studies.
by: Aung Zaw Win, et al.
Published: (2014-01-01)

The Value of <sup>68</sup>Ga-PSMA PET/CT Following Equivocal <sup>18</sup>F-NaF PET/CT in Prostate Cancer Patients
by: Claus Madsen, et al.
Published: (2020-05-01)

Nasopharyngeal tuberculosis incidentally diagnosed on 18F-FDG PET/CT
by: Laurence Champion, et al.
Published: (2020-04-01)

Interim and end-treatment 18F-Fluorocholine PET/CT and bone scan in prostate cancer patients treated with Radium 223 dichloride
by: Ana María García Vicente, et al.
Published: (2021-04-01)

18F-NaF PET/CT imaging of bone formation induced by bioactive glass S53P4 after mastoid obliteration
by: Adriana J. Timmermans, et al.
Published: (2019-10-01)

Can <sup>18</sup>F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?
by: Christos Sachpekidis, et al.
Published: (2020-05-01)

Comparison of standardized uptake values measured on 18F-NaF PET/CT scans using three different tube current intensities
by: Agnes Araujo Valadares, et al.
Published: (2015-02-01)

To Evaluate The Biokinetic Model For Healthy Person Undergone NaF-18 PET/CT Examination Via MATLAB Analysis
by: Liu, Shih-Jyun, et al.
Published: (2014)

Occult Hip Prosthetic Loosening Diagnosed by [18F] Fluoride-PET/CT
by: Gösta Ullmark, MD, PhD
Published: (2020-09-01)

Sacroiliac joint asymmetry regarding inflammation and bone turnover: Assessment by FDG and NaF PET/CT
by: Abdullah Al-zaghal, et al.
Published: (2019-06-01)

18F-FET-PET in Primary Hyperparathyroidism: A Pilot Study
by: Martin Krakauer, et al.
Published: (2016-08-01)

Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
by: E. Quaquarini, et al.
Published: (2019-01-01)

Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer
by: Samuli Arvola, et al.
Published: (2019-01-01)

Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to 18F-FDG PET/CT
by: Dong Zheng, et al.
Published: (2020-06-01)

Dural Metastases of Advanced Prostate Cancer Detected by <sup>18</sup>F-Fluorocholine
by: Mauro Morassi, et al.
Published: (2020-06-01)

Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer
by: Hodolic Marina, et al.
Published: (2014-09-01)

Perfusion CT and PET with 18F–FDG and 18F–FCh in the complex diagnosis of hepatocellular carcinoma
by: P. E. Tulin, et al.
Published: (2017-12-01)